UPDATED Apr 26, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$782.00 | 4.3% | 55.8% | NT$20.3t | NT$912.98 | PE23.7x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£119.88 | 9.5% | 2.1% | UK£185.8b | UK£131.52 | PE36.7x | E16.5% | 2.1% | Pharmaceuticals & Biotech | ||
NOVN | CHF89.50 | 4.6% | -1.8% | CHF182.6b | CHF99.16 | PE21.9x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF221.00 | -0.5% | -21.2% | CHF178.2b | CHF279.39 | PE15.3x | E8.6% | 4.3% | Pharmaceuticals & Biotech | ||
AIR | €157.06 | -1.9% | 23.5% | €124.2b | €177.30 | PE31.7x | E17.9% | 1.1% | Capital Goods | ||
SLB | US$49.20 | -1.3% | -0.3% | US$70.3b | US$67.11 | PE16.2x | E14.7% | 2.2% | Energy | ||
ZURN | CHF439.90 | -1.9% | 1.9% | CHF63.3b | CHF459.23 | PE15.9x | E8.6% | 5.9% | Insurance | ||
NTES | US$95.99 | 2.7% | 7.7% | US$60.0b | US$132.85 | PE14.8x | E7.9% | 2.6% | Media | ||
2454 | NT$1,005.00 | 1.2% | 51.1% | NT$1.6t | NT$1,199.29 | PE20.8x | E14.0% | 6.0% | Semiconductors | ||
BBRI | Rp4,830.00 | -8.4% | -5.3% | Rp776.6t | Rp6,591.96 | PB2.5x | E11.9% | 6.6% | Banks | ||
BMRI | Rp6,750.00 | 0.4% | 30.4% | Rp648.7t | Rp7,544.68 | PB2.4x | E9.4% | 5.2% | Banks | ||
2020 | HK$90.00 | 7.4% | -7.0% | HK$254.9b | HK$111.78 | PE23.1x | E13.0% | 2.5% | Consumer Durables | ||
EVO | kr1,263.50 | -1.4% | -7.5% | kr266.7b | kr1,487.77 | PE20.9x | E12.4% | 2.5% | Consumer Services | ||
300274 | CN¥99.27 | 4.3% | -11.9% | CN¥145.8b | CN¥131.17 | PE14.5x | E11.1% | 1.0% | Capital Goods | ||
KCHOL | ₺217.00 | -1.3% | 186.8% | ₺550.3b | ₺215.07 | PE7.6x | E26.5% | 3.7% | Capital Goods | ||
SOON | CHF257.00 | 3.6% | -8.8% | CHF15.3b | CHF270.88 | PE25.5x | E10.7% | 1.8% | Healthcare | ||
ALL | AU$40.20 | -0.3% | 6.0% | AU$25.5b | AU$47.49 | PE17.5x | E5.1% | 1.7% | Consumer Services | ||
300015 | CN¥12.63 | 4.0% | -44.3% | CN¥117.8b | CN¥21.32 | PE33.9x | E18.6% | 0.6% | Healthcare | ||
2027 | CN¥6.85 | -1.4% | 6.4% | CN¥98.9b | CN¥8.02 | PE23.2x | E19.0% | 6.1% | Media | ||
JMT | €19.03 | 7.0% | -16.9% | €12.0b | €23.34 | PE15.8x | E7.4% | 3.4% | Consumer Retailing | ||
300122 | CN¥34.83 | -14.0% | -35.8% | CN¥83.4b | CN¥62.47 | PE11.1x | E23.8% | 2.3% | Pharmaceuticals & Biotech | ||
600845 | CN¥39.77 | 6.1% | -11.6% | CN¥80.8b | CN¥49.57 | PE36.1x | E21.4% | 2.5% | Software | ||
2050 | CN¥22.16 | 6.4% | -5.1% | CN¥79.4b | CN¥31.83 | PE25.6x | E19.2% | 1.1% | Capital Goods | ||
ALV | US$122.29 | 6.5% | 42.5% | US$10.1b | US$126.35 | PE18.7x | E21.2% | 2.2% | Automobiles |